Targeting stem cells with oncolytic viruses: a mathematical modelling approach

Area of Science:

• Oncology
• Virology
• Mathematical Biology

Background:

• Intratumoural epigenetic heterogeneity arises from a stem cell-differentiated cell hierarchy.
• Cancer stem cells (CSCs), or tumour-initiating cells, drive tumour growth via self-renewal and differentiation.
• Oncolytic viral therapy offers targeted cancer cell destruction with minimal harm to normal cells.

Purpose of the Study:

• To investigate the optimal values for virus infectivity and stem cell specificity in oncolytic viral therapy.
• To model the interactions within a CSC-differentiated cell hierarchy during oncolytic viral treatment.
• To determine conditions for achieving long-term tumour shrinkage.

Main Methods:

• Mathematical modeling of cancer stem cell and differentiated cell interactions.
• Calculation of the basic reproduction number to constrain infectivity rates.
• Analysis of virus infectivity, stem cell specificity, and mitotic rates.

Main Results:

• Long-term tumour shrinkage is achievable only when a specific constraint on infectivity rates is met.
• Stem cell specificity is influenced by average infectivity and mitotic rates of infected cells.
• For nonmitotic cells, high infectivity coupled with high stem cell specificity reduces tumour size; low infectivity favors targeting differentiated cells.

Conclusions:

• Oncolytic virus efficacy is highly dependent on the balance between infectivity and targeting specific cell populations (stem vs. differentiated).
• The study provides conditions for minimizing tumour size under different infectivity and specificity scenarios.
• A perfect stem cell targeting regimen requires specific conditions to achieve maximal tumour reduction.